唾液IgA抗MAA-LDL与口腔病原体同冠心病相关
研究纳入451例接受冠状动脉造影患者(无CAD 133例、稳定CAD 169例、ACS 149例),检测唾液IgA抗体。稳定CAD和ACS患者抗MAA-LDL、Rgp44、Aa-HSP60等IgA水平升高,校正心血管危险因素后与CAD相关,且抗MAA-LDL与口腔病原体存在交叉反应。
要点
- 稳定CAD和ACS患者唾液IgA抗MAA-LDL、Rgp44、Aa-HSP60水平高于无CAD者。
- 校正心血管危险因素后,唾液IgA与CAD的关联仍显著。
- 唾液IgA抗MAA-LDL与受试口腔病原体存在交叉反应。
核心结论
- 唾液IgA抗MAA-LDL与动脉粥样硬化相关,但与CAD的因果关系尚待阐明。
研究设计与样本
- 研究纳入451例接受冠状动脉造影患者,分为无CAD(n=133)、稳定CAD(n=169)和ACS(n=149)三组。
主要发现
- 稳定CAD和ACS患者唾液IgA抗MAA-LDL、Rgp44和Aa-HSP60水平高于无CAD患者。
关键数值与推荐
- 多因素回归中,稳定CAD与ACS分别与IgA抗MAA-LDL相关(P=0.016,P=0.043)。
- 稳定CAD与ACS分别与IgA抗Rgp44相关(P=0.012,P=0.004)。
- 稳定CAD与ACS分别与IgA抗Aa-HSP60相关(P=0.032,P=0.030)。
- 稳定CAD与ACS分别与IgA抗Tannerella forsythia相关(P=0.002,P=0.004)。
- 稳定CAD与ACS分别与IgA抗Porphyromonas endodontalis相关(P=0.016,P=0.020)。
临床怎么用
- 唾液IgA抗MAA-LDL及口腔病原体抗体或可作为CAD相关口腔免疫标志物供进一步研究。
局限性
- 唾液IgA抗MAA-LDL及相关口腔体液免疫反应在CAD发生中的因果作用尚不明确,需未来研究阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A large body of literature has established the link between periodontal disease and cardiovascular disease. Oxidized low-density lipoproteins (OxLDLs) have a crucial role in atherosclerosis progression through initiation of immunological response. Monoclonal IgM antibodies to malondialdehyde-modified low-density lipoprotein (MDA-LDL) and to malondialdehyde acetaldehyde-modified low-density lipoprotein (MAA-LDL) have been shown to cross-react with the key virulence factors of periodontal pathogens Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. We have previously shown that salivary IgA antibodies to MAA-LDL cross-react with P. gingivalis in healthy humans. In this study, we aim to assess whether oral mucosal immune response represented by salivary IgA to MAA-LDL and oral pathogens is associated with coronary artery disease (CAD). Also, the molecular mimicry through antibody cross-reaction between salivary IgA to MAA-LDL and oral pathogens was evaluated. The study subjects consisted of 451 patients who underwent a coronary angiography with no CAD ( n = 133), stable CAD ( n = 169), and acute coronary syndrome (ACS, n = 149). Elevated salivary IgA antibody levels to MAA-LDL, Rgp44 (gingipain A hemagglutinin domain of P. gingivalis), and Aa-HSP60 (heat shock protein 60 of A. actinomycetemcomitans) were discovered in stable-CAD and ACS patients when compared to no-CAD patients. In a multinomial regression model adjusted for known cardiovascular risk factors, stable CAD and ACS were associated with IgA to MAA-LDL ( P = 0.016, P = 0.043), Rgp44 ( P = 0.012, P = 0.004), Aa-HSP60 ( P = 0.032, P = 0.030), Tannerella forsythia ( P = 0.002, P = 0.004), Porphyromonas endodontalis ( P = 0.016, P = 0.020), Prevotella intermedia ( P = 0.038, P = 0.005), and with total IgA antibody concentration ( P = 0.002, P = 0.016). Salivary IgA to MAA-LDL showed cross-reactivity with the oral pathogens tested in the study patients. The study highlights an association between salivary IgA to MAA-LDL and atherosclerosis. However, whether salivary IgA to MAA-LDL and the related oral humoral responses play a causal role in the development in the CAD should be elucidated in the future.
引用
- Akhi R, Wang C, Nissinen AE, et al. Salivary IgA to MAA-LDL and Oral Pathogens Are Linked to Coronary Disease. J Dent Res. 2019. PMID: 30669938. doi:10.1177/0022034518818445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。